Scranton is ready to begin a sweeping $27.3 million plan to change downtown traffic patterns, signals and streetscapes to improve pedestrian and vehicle safety, Mayor Paige G. Cognetti announced ...
Q3 2025 Earnings Call October 23, 2025 9:30 AM EDTCompany ParticipantsGregory Bardi - Vice President of Investor ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. The defending World Series champion Los Angeles ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Another chapter in one of baseball’s most prolific ...
If your new phone no longer supports SIM cards, or you don't want to use them anymore, you can convert to eSIM instead. I started my career with CNET all the way back in 2005, when the (original) ...
The San Diego Padres defeated the Chicago Cubs 3-0 in Game 2 of the National League Wild Card Series on Wednesday to force a winner-take-all Game 3 on Thursday. The winner will move on to the ...
Dear Mom: The good and the bad news is that this may be a phase that she’s going through, and not permanent. But it still needs redirection. You can help her develop emotional maturity by being clear ...
Genmab is continuing to build up its pipeline of wholly owned late-stage cancer assets, this time paying $8 billion for Netherlands-based Merus and its bispecific antibody. Analysts praised the ...
Tickets to the 2026 World Cup are now on sale, but that doesn’t mean you can simply go buy them. The World Cup ticket process is a labyrinth of lotteries, long waits, fluctuating prices and ...
Hosted on MSN
Mumbai Metro Phase 3 Inauguration | Inside Mumbai Metro Line 3 Final Phase, PM Modi To Inaugurate
Mumbai Metro Phase 3 Inauguration | Inside Mumbai Metro Line 3 Final Phase, PM Modi To Inaugurate Mumbai Metro Line 3 (Aqua Line) is scheduled to fully open on Oct. 8. It is the city’s first ...
Metsera, Inc. (NASDAQ:MTSR) on Tuesday released topline data from VESPER-1 and data from a planned interim analysis for tolerability of VESPER-3 – two Phase 2b trials of MET-097i with potential for ...
Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the financial firepower to deliver data from two phase 3 trials next year. San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback